{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:29:22Z","timestamp":1783488562177,"version":"3.55.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The vascular endothelium responds to infection by destabilizing endothelial cell\u2013cell junctions to allow fluid and cells to pass into peripheral tissues, facilitating clearance of infection and tissue repair. During sepsis, endotoxin and other proinflammatory molecules induce excessive vascular leak, which can cause organ dysfunction, shock, and death. Current therapies for sepsis are limited to antibiotics and supportive care, which are often insufficient to reduce morbidity and prevent mortality. Previous attempts at blocking inflammatory cytokine responses in humans proved ineffective at reducing the pathologies associated with sepsis, highlighting the need for a new therapeutic strategy. The small GTPase ARF6 is activated by a MyD88\u2013ARNO interaction to induce vascular leak through disruption of endothelial adherens junctions. In this study, we show that the MyD88\u2013ARNO\u2013ARF6\u2013signaling axis is responsible for LPS-induced endothelial permeability and is a destabilizing convergence point used by multiple inflammatory cues. We also show that blocking ARF6 with a peptide construct of its N terminus is sufficient to reduce vascular leak and enhance survival during endotoxic shock, without inhibiting the host cytokine response. Our data highlight the therapeutic potential of blocking ARF6 and reducing vascular leak for the treatment of inflammatory conditions, such as endotoxemia.<\/jats:p>","DOI":"10.4049\/jimmunol.1400309","type":"journal-article","created":{"date-parts":[[2014,5,17]],"date-time":"2014-05-17T08:19:35Z","timestamp":1400314775000},"page":"6045-6052","source":"Crossref","is-referenced-by-count":46,"title":["ARF6 Inhibition Stabilizes the Vasculature and Enhances Survival during Endotoxic Shock"],"prefix":"10.1093","volume":"192","author":[{"given":"Chadwick T","family":"Davis","sequence":"first","affiliation":[{"name":"Department of Human Genetics, University of Utah , Salt Lake City, UT 84112"},{"name":"Program in Molecular Medicine, University of Utah , Salt Lake City, UT 84112"},{"name":"Department of Medicine, University of Utah , Salt Lake City, UT 84112"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiquan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Program in Molecular Medicine, University of Utah , Salt Lake City, UT 84112"},{"name":"Department of Medicine, University of Utah , Salt Lake City, UT 84112"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C","family":"Gibson","sequence":"additional","affiliation":[{"name":"Program in Molecular Medicine, University of Utah , Salt Lake City, UT 84112"},{"name":"Department of Medicine, University of Utah , Salt Lake City, UT 84112"},{"name":"Department of Bioengineering, University of Utah , Salt Lake City, UT 84112"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay A","family":"Bowman-Kirigin","sequence":"additional","affiliation":[{"name":"Program in Molecular Medicine, University of Utah , Salt Lake City, UT 84112"},{"name":"Department of Medicine, University of Utah , Salt Lake City, UT 84112"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Sorensen","sequence":"additional","affiliation":[{"name":"Program in Molecular Medicine, University of Utah , Salt Lake City, UT 84112"},{"name":"Department of Medicine, University of Utah , Salt Lake City, UT 84112"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ling","sequence":"additional","affiliation":[{"name":"Program in Molecular Medicine, University of Utah , Salt Lake City, UT 84112"},{"name":"Department of Medicine, University of Utah , Salt Lake City, UT 84112"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiming","family":"Sun","sequence":"additional","affiliation":[{"name":"Program in Molecular Medicine, University of Utah , Salt Lake City, UT 84112"},{"name":"Department of Medicine, University of Utah , Salt Lake City, UT 84112"},{"name":"Department of Respiratory and Critical Care Medicine, Jinling Hospital, Clinical School of Nanjing University , Nanjing 210002,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutip","family":"Navankasattusas","sequence":"additional","affiliation":[{"name":"Program in Molecular Medicine, University of Utah , Salt Lake City, UT 84112"},{"name":"Department of Medicine, University of Utah , Salt Lake City, UT 84112"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean Y","family":"Li","sequence":"additional","affiliation":[{"name":"Program in Molecular Medicine, University of Utah , Salt Lake City, UT 84112"},{"name":"Department of Medicine, University of Utah , Salt Lake City, UT 84112"},{"name":"Department of Oncological Sciences, University of Utah , Salt Lake City, UT 84112"},{"name":"Division of Cardiology, Department of Medicine, University of Utah , Salt Lake City, UT 84112"},{"name":"The Key Laboratory for Human Disease Gene Study of Sichuan Province, Institute of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People\u2019s Hospital , Chengdu, Sichuan 610072,","place":["China"]},{"name":"Cardiology Section, VA Salt Lake City Health Care System , Salt Lake City, UT 84112"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,6,15]]},"reference":[{"key":"2025032404334535000_r1","doi-asserted-by":"crossref","first-page":"23ra19","DOI":"10.1126\/scitranslmed.3000678","article-title":"Targeting Robo4-Dependent Slit Signaling to Survive the Cytokine Storm in Sepsis and Influenza","volume":"2","author":"London","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"2025032404334535000_r2","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature01326","article-title":"The immunopathogenesis of sepsis","volume":"420","author":"Cohen","year":"2002","journal-title":"Nature"},{"key":"2025032404334535000_r3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMcibr1007320","article-title":"Sepsis and endothelial permeability","volume":"363","author":"Lee","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"2025032404334535000_r4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med."},{"key":"2025032404334535000_r5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1164\/rccm.2201087","article-title":"Current epidemiology of septic shock: the CUB-R\u00e9a Network","volume":"168","author":"Annane","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2025032404334535000_r6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"2025032404334535000_r7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nm0503-517","article-title":"Novel strategies for the treatment of sepsis","volume":"9","author":"Riedemann","year":"2003","journal-title":"Nat. Med."},{"key":"2025032404334535000_r8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2110-5820-1-7","article-title":"Corticosteroids for severe sepsis: an evidence-based guide for physicians","volume":"1","author":"Annane","year":"2011","journal-title":"Ann. Intensive care"},{"key":"2025032404334535000_r9","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jama.2013.2194","article-title":"Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial","volume":"309","author":"Opal","year":"2013","journal-title":"JAMA"},{"issue":"7","key":"2025032404334535000_r10","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/00003246-200107001-00037","article-title":"Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned","volume":"29","author":"Reinhart","year":"2001","journal-title":"Crit. Care Med."},{"key":"2025032404334535000_r11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","article-title":"Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group","volume":"25","author":"Opal","year":"1997","journal-title":"Crit. Care Med."},{"key":"2025032404334535000_r12","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/330662a0","article-title":"Anti-cachectin\/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia","volume":"330","author":"Tracey","year":"1987","journal-title":"Nature"},{"key":"2025032404334535000_r13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1473-3099(07)70265-7","article-title":"Host-pathogen interactions in sepsis","volume":"8","author":"van der Poll","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"2025032404334535000_r14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4049\/jimmunol.1203103","article-title":"MyD88: a critical adaptor protein in innate immunity signal transduction","volume":"190","author":"Warner","year":"2013","journal-title":"J. Immunol."},{"key":"2025032404334535000_r15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature11603","article-title":"Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability","volume":"492","author":"Zhu","year":"2012","journal-title":"Nature"},{"key":"2025032404334535000_r16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0076-6879(08)02008-9","article-title":"An assay system for in vitro detection of permeability in human \u201cendothelium.\u201d","volume":"443","author":"Martins-Green","year":"2008","journal-title":"Methods Enzymol."},{"key":"2025032404334535000_r17","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/ncb1486","article-title":"VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin","volume":"8","author":"Gavard","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"2025032404334535000_r18","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1182\/blood.V71.5.1366.1366","article-title":"Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin","volume":"71","author":"Moake","year":"1988","journal-title":"Blood"},{"key":"2025032404334535000_r19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10439-010-0142-z","article-title":"Novel approach for endothelializing vascular devices: understanding and exploiting elastin-endothelial interactions","volume":"39","author":"Wilson","year":"2011","journal-title":"Ann. Biomed. Eng."},{"key":"2025032404334535000_r20","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1172\/JCI112232","article-title":"Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro","volume":"76","author":"Zimmerman","year":"1985","journal-title":"J. Clin. Invest."},{"key":"2025032404334535000_r21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1084\/jem.20040224","article-title":"Activated polymorphonuclear leukocytes rapidly synthesize retinoic acid receptor-alpha: a mechanism for translational control of transcriptional events","volume":"200","author":"Yost","year":"2004","journal-title":"J. Exp. Med."},{"key":"2025032404334535000_r22","volume-title":"Hemodynamics.","author":"Milnor","year":"1982"},{"key":"2025032404334535000_r23","first-page":"e50062","article-title":"An in vivo assay to test blood vessel permeability","volume":"16","author":"Radu","year":"2013","journal-title":"J. Vis. Exp."},{"key":"2025032404334535000_r24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1172\/JCI200214211","article-title":"Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor","volume":"109","author":"Han","year":"2002","journal-title":"J. Clin. Invest."},{"key":"2025032404334535000_r25","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1074\/jbc.M109.079277","article-title":"Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers","volume":"285","author":"Adam","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2025032404334535000_r26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1128\/CVI.00257-07","article-title":"Human skin endothelial cells can express all 10 TLR genes and respond to respective ligands","volume":"15","author":"Fitzner","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"2025032404334535000_r27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4049\/jimmunol.1302021","article-title":"Slit2-Robo4 pathway modulates lipopolysaccharide-induced endothelial inflammation and its expression is dysregulated during endotoxemia","volume":"192","author":"Zhao","year":"2014","journal-title":"J. Immunol."},{"key":"2025032404334535000_r28","doi-asserted-by":"crossref","first-page":"11058","DOI":"10.1074\/jbc.275.15.11058","article-title":"Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells","volume":"275","author":"Faure","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2025032404334535000_r29","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4049\/jimmunol.0901654","article-title":"Cytohesin-1 regulates the Arf6-phospholipase D signaling axis in human neutrophils: impact on superoxide anion production and secretion","volume":"184","author":"El Azreq","year":"2010","journal-title":"J. Immunol."},{"key":"2025032404334535000_r30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ncb1672","article-title":"GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion","volume":"10","author":"Morishige","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"2025032404334535000_r31","doi-asserted-by":"crossref","first-page":"ra14","DOI":"10.1126\/scisignal.2003398","article-title":"The small GTPase ARF6 stimulates \u03b2-catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasis","volume":"6","author":"Grossmann","year":"2013","journal-title":"Sci. Signal."},{"key":"2025032404334535000_r32","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0968-0004(02)02145-X","article-title":"A universal role for MyD88 in TLR\/IL-1R-mediated signaling","volume":"27","author":"Janssens","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"2025032404334535000_r33","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1074\/jbc.M109.000414","article-title":"Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation","volume":"284","author":"Clark","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2025032404334535000_r34","doi-asserted-by":"crossref","first-page":"32861","DOI":"10.1074\/jbc.M211439200","article-title":"A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts","volume":"278","author":"Kishore","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2025032404334535000_r35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1152\/physrev.00012.2005","article-title":"Signaling mechanisms regulating endothelial permeability","volume":"86","author":"Mehta","year":"2006","journal-title":"Physiol. Rev."},{"key":"2025032404334535000_r36","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1182\/blood-2005-09-3563","article-title":"Arf6 plays an early role in platelet activation by collagen and convulxin","volume":"107","author":"Choi","year":"2006","journal-title":"Blood"},{"key":"2025032404334535000_r37","doi-asserted-by":"crossref","first-page":"14809","DOI":"10.1074\/jbc.270.24.14809","article-title":"The myristoylated amino terminus of ADP-ribosylation factor 1 is a phospholipid- and GTP-sensitive switch","volume":"270","author":"Randazzo","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2025032404334535000_r38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev-physiol-021909-135833","article-title":"Regulation of endothelial permeability via paracellular and transcellular transport pathways","volume":"72","author":"Komarova","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"2025032404334535000_r39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.devcel.2007.10.019","article-title":"Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia","volume":"14","author":"Gavard","year":"2008","journal-title":"Dev. Cell"},{"key":"2025032404334535000_r40","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/ncb1976","article-title":"Slit2-Robo4 signalling promotes vascular stability by blocking Arf6 activity","volume":"11","author":"Jones","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"2025032404334535000_r41","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.cell.2006.03.047","article-title":"Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling","volume":"125","author":"Kagan","year":"2006","journal-title":"Cell"},{"key":"2025032404334535000_r42","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1074\/jbc.M113.499194","article-title":"The small GTPase Arf6 is essential for the Tram\/Trif pathway in TLR4 signaling","volume":"17","author":"Van Acker","year":"2014","journal-title":"J. Biol. Chem."},{"key":"2025032404334535000_r43","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/eji.200737331","article-title":"A role for ARF6 in dendritic cell podosome formation and migration","volume":"38","author":"Svensson","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"2025032404334535000_r44","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1128\/MCB.00298-06","article-title":"Crucial role of the small GTPase ARF6 in hepatic cord formation during liver development","volume":"26","author":"Suzuki","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"2025032404334535000_r45","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nature05415","article-title":"Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance","volume":"444","author":"Hafner","year":"2006","journal-title":"Nature"},{"key":"2025032404334535000_r46","doi-asserted-by":"crossref","first-page":"e23359","DOI":"10.1371\/journal.pone.0023359","article-title":"GEP100-Arf6-AMAP1-cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis","volume":"6","author":"Hashimoto","year":"2011","journal-title":"PLoS ONE"},{"key":"2025032404334535000_r47","doi-asserted-by":"crossref","first-page":"e43532","DOI":"10.1371\/journal.pone.0043532","article-title":"ARF6-dependent regulation of P2Y receptor traffic and function in human platelets","volume":"7","author":"Kanamarlapudi","year":"2012","journal-title":"PLoS ONE"},{"key":"2025032404334535000_r48","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s12975-011-0125-x","article-title":"Blood-brain barrier pathophysiology in traumatic brain injury","volume":"2","author":"Chodobski","year":"2010","journal-title":"Transl. Stroke Res."},{"key":"2025032404334535000_r49","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awl318","article-title":"Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy","volume":"130","author":"van Vliet","year":"2007","journal-title":"Brain"},{"key":"2025032404334535000_r50","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1191\/1352458503ms965oa","article-title":"Blood-brain barrier disruption in multiple sclerosis","volume":"9","author":"Minagar","year":"2003","journal-title":"Mult. Scler."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/192\/12\/6045\/61760957\/1400309.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/192\/12\/6045\/61760957\/1400309.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T13:58:11Z","timestamp":1742824691000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/192\/12\/6045\/8001640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,6,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1400309","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,6]]},"published":{"date-parts":[[2014,6]]}}}